Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-027015)

Filing Details

Accession Number:: 0001209191-12-027015
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-09 13:00:00
Reporting Period:: 2012-05-07

Filing Date:: 2012-05-09
Accepted Time:: 2012-05-09 16:36:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1349077	Lisa Kelly	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139	Svp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-05-07	28,593	$32.16	57,168	No	4	M	Direct
Common Stock	Acquisiton	2012-05-07	3,813	$32.16	60,981	No	4	M	Direct
Common Stock	Disposition	2012-05-07	16,242	$55.00	44,739	No	4	S	Direct
Common Stock	Disposition	2012-05-07	7,187	$52.13	37,552	No	4	S	Direct
Common Stock	Disposition	2012-05-07	14,297	$57.50	23,255	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2012-05-07	28,593	$0.00	28,593	$32.16
Common Stock	Stock Option	Disposition	2012-05-07	3,813	$0.00	3,813	$18.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,907	2008-10-24	2018-07-23	No	4	M	Direct
0		2018-02-06	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,667	Indirect	401(k)

Footnotes

Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Fully vested.